AcrySof IQ Toric A-Code Post-Market Clinical Study
AcrySof IQ Toric A-Code Post-Market Clinical Study
The purpose of this study is to clinically confirm the rotational stability of a modified
 AcrySof IQ toric intraocular lens (IOL) in a Japanese population.
Patients will be examined pre-operatively to up to 3 years post-operatively. One eligible eye
 will be selected as a target eye for efficacy analysis. If both eyes are eligible, the eye in
 which the IOL is implanted first will be selected as the target eye.

 An interim analysis of results through Visit 4 (Day 120-180) is provided.
Inclusion Criteria:

 -  Diagnosis of cataracts with planned cataract removal by phacoemulsification

 -  Calculated lens power within the available range

 -  Able to sign informed consent and complete all study visits

 -  Other protocol-defined inclusion criteria may apply.

 Exclusion Criteria:

 -  Eye conditions as specified in the protocol

 -  Uncontrolled glaucoma

 -  Pregnancy, current or planned

 -  Other protocol-defined exclusion criteria may apply.